الجمعة، 6 يناير 2012

ROWATINEX

For the Treatment & Prevention ot Urolithiasis, Nephrolithiasis & Other Urinary Tract Disorders Composition Each capsule contains:
Properties The therapeutic effect of ROWATINEX® in urinary tract disorders is due to its appropriate balanced combination of different components. In renal and urinary tract disorders an obvious rapid improvement is achieved, leading to elimination of complaints through: Improving the renal blood flow, thus stimulating the kidneys and giving rise to increased urine excretion, elimination of stasis, prevention of urinary tract infections resulting from stasis, an increase of the protective colloids in the urine which effectively prevents stone formation and inflammation, and relieving the inflammation of urinary tract and disorders associated with urolithiasis which usually improve within d Very Short time. A regular daily administration of ROWATINEX® reduces the frequency of renal colic and the attacks eventually cease. In many cases the antispasmodic action of the drug facilitates the elimination of calculi. ROWATINEX® Capsule, being soluble in the small intestine, suits patients with gastric disorders. Indications • Treatment and prophylaxis of urolithiasis and nephrolithiasis • Urinary tract infections • Renal colic Contraindications None known Dosage Unless otherwise prescribed by-the physician, the dose is 1-2 capsules 3 times daily, half an hour before meals. How Supplied Strips of 15 capsules in packs of 2 strips. ' Storage Store in a cool dry place, below 25°C.
Keep all medications out of reach of childwo
ILE4A
tylanufectured by: ROWA-WAGNER,Germany. 0 PACKED BY &- AMOUN PHARMACEUTICAL CO. S.A E. El-Obour City, Cairo, Egypt.
MIMI
Alpha Pinene 24.8 mg Beta l'inene 62 mg Camphene 15mg Bomeol 10mg Anethol 4 mg Fenchone 4 mg Cineol 3 mg Olive Oil q.s.add to 100 mg

ليست هناك تعليقات:

إرسال تعليق